X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (843) 843
Publication (154) 154
Book Review (96) 96
Conference Proceeding (35) 35
Newspaper Article (29) 29
Book / eBook (27) 27
Web Resource (20) 20
Patent (18) 18
Book Chapter (15) 15
Dissertation (4) 4
Magazine Article (3) 3
Newsletter (3) 3
Report (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (491) 491
humans (458) 458
hematology (297) 297
female (235) 235
male (228) 228
middle aged (218) 218
oncology (215) 215
adult (208) 208
aged (174) 174
abridged index medicus (140) 140
treatment outcome (127) 127
chemotherapy (107) 107
antineoplastic agents - therapeutic use (102) 102
prognosis (93) 93
cancer (92) 92
antineoplastic combined chemotherapy protocols - therapeutic use (88) 88
remission induction (88) 88
adolescent (85) 85
article (85) 85
acute myeloid-leukemia (78) 78
leukemia, promyelocytic, acute - drug therapy (77) 77
therapy (75) 75
aged, 80 and over (70) 70
trans-retinoic acid (68) 68
young adult (68) 68
acute promyelocytic leukemia (67) 67
leukemia (64) 64
acute myelogenous leukemia (62) 62
acute myeloid leukemia (60) 60
survival analysis (60) 60
leukemia, myeloid, acute - drug therapy (58) 58
transplantation (55) 55
disease-free survival (53) 53
arsenic trioxide (51) 51
mutation (51) 51
hematology, oncology and palliative medicine (49) 49
recurrence (49) 49
analysis (48) 48
hemic and lymphatic diseases (48) 48
survival rate (47) 47
animals (45) 45
leukemia, myeloid, acute - genetics (45) 45
research (42) 42
hematopoietic stem cell transplantation (41) 41
tretinoin - therapeutic use (41) 41
acute disease (38) 38
antineoplastic agents - adverse effects (38) 38
leukemia, myeloid, acute - therapy (38) 38
risk factors (38) 38
stem-cell transplantation (38) 38
survival (38) 38
bone-marrow-transplantation (37) 37
minimal residual disease (34) 34
follow-up studies (33) 33
remission (33) 33
retrospective studies (33) 33
cytarabine - administration & dosage (32) 32
clinical trials and observations (31) 31
leukemia, myeloid, acute - mortality (31) 31
antineoplastic combined chemotherapy protocols - adverse effects (30) 30
clinical trials as topic (30) 30
cytogenetics (30) 30
child (29) 29
christianity (29) 29
neurology (29) 29
time factors (29) 29
arsenicals - therapeutic use (28) 28
leukemia, myeloid, acute - diagnosis (28) 28
leukemia, promyelocytic, acute - mortality (28) 28
relapse (28) 28
clinical trials (27) 27
immunology (27) 27
oxides - therapeutic use (27) 27
daunorubicin - administration & dosage (26) 26
aml (25) 25
expression (25) 25
protestant reformation (25) 25
transplantation, homologous (25) 25
trial (25) 25
care and treatment (24) 24
differentiation (24) 24
health aspects (24) 24
cladribine - therapeutic use (23) 23
genetic aspects (23) 23
mice (23) 23
religious organizations (23) 23
tretinoin - administration & dosage (23) 23
all-trans retinoic acid (22) 22
child, preschool (22) 22
hematopoietic stem cell transplantation - methods (22) 22
risk (22) 22
spirituality (22) 22
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
complete remission (21) 21
induction chemotherapy (21) 21
leukemia, promyelocytic, acute - complications (21) 21
adults (20) 20
antineoplastic agents - administration & dosage (20) 20
bone marrow - pathology (20) 20
cells (20) 20
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
UTL at Downsview - May be requested (4) 4
Gerstein Science - Stacks (3) 3
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Knox College (Caven) - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - WERC (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, Best practice & research. Clinical haematology, Volume 19, no. 4., 635-847
Book
2003, Best practice & research., Volume 16, no. 3., vii, 347-543, iii p.
Book
2002, Seminars in hematology, Volume 39, no. 4, suppl. 3., 37
Book
Current Opinion in Hematology, ISSN 1065-6251, 03/2015, Volume 22, Issue 2, p. v
Journal Article
Seminars in Hematology, ISSN 0037-1963, 04/2019, Volume 56, Issue 2, pp. 83 - 83
Journal Article
2000, Advances in blood disorders, ISBN 9789058230096, Volume 5, xiii, 189
Book
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 09/2019, Volume 45, Issue 6, pp. 612 - 621
Abstract Despite the improved therapeutic advances in the management of acute promyelocytic leukemia (APL), a significant early mortality during induction,... 
Review Article | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 454 - 464
Midostaurin, an oral multitargeted kinase inhibitor, is active in patients with a FLT3 mutation. Among patients with acute myeloid leukemia and this mutation,... 
TRIAL | INTERNAL TANDEM DUPLICATION | WILD-TYPE | MEDICINE, GENERAL & INTERNAL | FAVORABLE PROGNOSIS | ACUTE MYELOGENOUS LEUKEMIA | DISTINCT | TYROSINE KINASE INHIBITOR | SORAFENIB | PHASE-I | YOUNGER | Humans | Middle Aged | Kaplan-Meier Estimate | Staurosporine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Staurosporine - analogs & derivatives | Protein Kinase Inhibitors - adverse effects | Cytarabine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Mutation | Daunorubicin - administration & dosage | Leukemia, Myeloid, Acute - genetics | Staurosporine - administration & dosage | Chemotherapy | Care and treatment | Myelocytic leukemia | Nonlymphoid leukemia | Research | Drug therapy | Cancer | Tyrosine | Medical research | Inhibitor drugs | Myeloid leukemia | Leukemia | Clinical trials | Oncology | Transplantation | Kinases | Patients | Cancer therapies | Survival | Cytarabine | Daunorubicin | Medical prognosis | Point mutation | Death | Remission | Acute myeloid leukemia | Protein-tyrosine kinase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Current Opinion in Hematology, ISSN 1065-6251, 03/2015, Volume 22, Issue 2, pp. 75 - 76
Journal Article
Current Opinion in Hematology, ISSN 1065-6251, 03/2011, Volume 18, Issue 2
Journal Article
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2014, Volume 27, Issue 1, pp. 1 - 1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 12, pp. 1079 - 1089
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 06/2019, Volume 60, Issue 7, pp. 1608 - 1609
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 07/2019, pp. 1 - 13
Immunotherapy in the form of allogeneic stem cell transplantation (SCT) plays an instrumental role in the treatment of acute myeloid leukemia (AML), with... 
Index Medicus
Journal Article
Blood, ISSN 0006-4971, 06/2013, Volume 121, Issue 24, pp. 4854 - 4860
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.